Bone Biologics Announces Significant Milestone For Spinal Fusion Surgery Using Recombinant Protein And Demineralized Bone Matrix

Bone Biologics, Inc. announced that it has successfully completed the initial primate trials validating the efficacy of the proprietary bone growth regeneration UCB-1 (NELL-1) protein in spinal fusion surgery. 100% fusion was obtained in a 3 month period. No cystic lesion was observed. The company is currently preparing Pre-IDE studies.

More: continued here

Filed under: Bones on February 25th, 2009